Grand Pharmaceutical Group financials at a glance

+ Portfolio

The revenue of Grand Pharmaceutical Group is reported as 10.52959 billion Dollars in the fiscal year 2023. The earnings were 0.54 Dollars per share in 2023, which was 8.47 lower than 2022. And about 2.19527 billion Dollars are reported as free cash flow in the financials of Grand Pharmaceutical Group 2023. Dividends of 0.26 Dollars per share were paid to shareholders of Grand Pharmaceutical Group stock SEHK:512 in fiscal 2023.

HK$10.53B

Revenue

HK$0.54

Earnings Per Share

61.96%

Gross Margin %

HK$2.32B

Free Cash Flow

Revenue

10,529.59

Earnings Per Share

0.54

Gross Margin %

61.96

Free Cash Flow

2,317.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2012	2010
Rev.	Revenue	N/A	HK$10.53B	HK$9.56B	HK$8.60B	HK$6.35B	HK$6.59B	HK$5.96B	HK$4.77B	HK$0.00M	HK$0.00M	HK$0.00M
GM %	Gross Margin %	63.45%	61.96%	62.24%	61.03%	63.52%	61.32%	53.06%	51.97%	46.87%	31.33%	35.54%
OM	Operating Margin	27.29%	27.16%	31.02%	25.37%	28.35%	21.38%	14.98%	13.96%	12.38%	7.15%	4.41%
EPS	Earnings Per Share	HK$0.68	HK$0.54	HK$0.59	HK$0.68	HK$0.52	HK$0.35	HK$0.27	HK$0.19	HK$0.12	HK$0.03	HK$0.07
Div.	Dividends	N/A	HK$0.26	HK$0.14	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00
PR %	Payout Ratio %	0	48.15%	23.73%	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	3,501.81M	3,519.27M	3,527.14M	3,549.57M	3,377.57M	3,134.83M	2,237.01M	2,237.01M	1,962.04M	1,920.8M
OCF	Operating Cash Flow	N/A	HK$2.68B	HK$1.84B	HK$2.01B	HK$1.46B	HK$1.29B	HK$0.00M	HK$719.72M	HK$0.00M	HK$0.00M	HK$0.00M
FCF	Free Cash Flow	N/A	HK$2.32B	HK$1.22B	HK$1.53B	HK$1.25B	HK$726.25M	HK$0.00M	HK$425.35M	HK$0.00M	HK$0.00M	HK$0.00M
FCFS	Free Cash Flow Per Share	HK$0.21	HK$0.55	HK$0.22	HK$0.41	HK$0.35	HK$0.22	HK$0.40	HK$0.17	HK$0.19	HK$-0.23	HK$0.08

Grand Pharmaceutical Group financials at a glance

Financials

Discover